Back
Cardiff Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
CRDF
Cardiff Oncology, Inc.
Last Price:
$1.83
Seasonality Move:
-3.36%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CRDF is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cardiff Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.86 | Buy |
| 20-day SMA: | 1.69 | Buy |
| 50-day SMA: | 2.27 | Sell |
| 200-day SMA: | 2.59 | Sell |
| 8-day EMA: | 1.86 | Buy |
| 20-day EMA: | 1.61 | Buy |
| 50-day EMA: | 1.06 | Buy |
| 200-day EMA: | 0.36 | Buy |
Cardiff Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 53.76 | Buy |
| Chaikin Money Flow: | 403918 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.54 - 1.84) | Buy |
| Bollinger Bands (100): | (1.8 - 2.7) | Sell |
Cardiff Oncology, Inc. Technical Analysis
| Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cardiff Oncology, Inc. Stock
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 1.98 while CRDF 8-day simple moving average is 1.86, which is a Buy signal.
-
The stock price of CRDF is 1.98 while Cardiff Oncology, Inc. 20-day SMA is 1.69, which makes it a Buy.
-
Cardiff Oncology, Inc. 50-day simple moving average is 2.27 while CRDF share price is 1.98, making it a Sell technically.
-
CRDF stock price is 1.98 and Cardiff Oncology, Inc. 200-day simple moving average is 2.59, creating a Sell signal.
CRDF Technical Analysis vs Fundamental Analysis
Sell
31
Cardiff Oncology, Inc. (CRDF)
is a Sell
Is Cardiff Oncology, Inc. a Buy or a Sell?
-
Cardiff Oncology, Inc. stock is rated a SellThe current Cardiff Oncology, Inc. [CRDF] share price is $1.98. The Score for CRDF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Cardiff Oncology, Inc. Stock Info
Market Cap:
135.4M
Price in USD:
1.98
Share Volume:
706.9K
Cardiff Oncology, Inc. 52-Week Range
52-Week High:
4.56
52-Week Low:
1.48
Sell
31
Cardiff Oncology, Inc. (CRDF)
is a Sell
Cardiff Oncology, Inc. Share Price Forecast
-
What is the Cardiff Oncology, Inc. stock price today?The Cardiff Oncology, Inc. stock price is 1.98 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology, Inc. is overvalued.
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 1.98 while CRDF 8-day exponential moving average is 1.86, which is a Buy signal.
-
The stock price of CRDF is 1.98 while Cardiff Oncology, Inc. 20-day EMA is 1.61, which makes it a Buy.
-
Cardiff Oncology, Inc. 50-day exponential moving average is 1.06 while CRDF share price is 1.98, making it a Buy technically.
-
CRDF stock price is 1.98 and Cardiff Oncology, Inc. 200-day simple moving average is 0.36, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology, Inc.
Is Cardiff Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.26 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Cardiff Oncology, Inc.
Should I short Cardiff Oncology, Inc. stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.31, suggesting Cardiff Oncology, Inc. is a Buy
-
Cardiff Oncology, Inc. Relative Strength Index (RSI) is 53.76, which suggest Cardiff Oncology, Inc. is overbought
-
The Bollinger Bands (25) for Cardiff Oncology, Inc. is (1.54 - 1.84), which suggest Cardiff Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Cardiff Oncology, Inc. is (1.8 - 2.7), which suggest Cardiff Oncology, Inc. is a Sell
* Cardiff Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.